Reyon Pharmaceutical Co., Ltd.(KR:102460)
₩9,650.00+210.00 (+2.22%)
KR:102460
Reyon Pharmaceutical Co., Ltd. Revenue
₩9,650.00
At close:+210.00 (+2.22%)
Want to see KR:102460 full AI Analyst Report?
Reyon Pharmaceutical Co., Ltd. (102460) Revenue
Reyon Pharmaceutical Co., Ltd. Revenue
Reyon Pharmaceutical Co., Ltd. had a revenue of 35.85B in the quarter ending Jun 30, 2026, with -0.57%. This bring the company's revenue in the last twelve months to 143.37B, Decreased 1.27%. In the fiscal year ending Dec 31, 2025, Reyon Pharmaceutical Co., Ltd. had annual revenue of 145.93B with -1.60% growth.
- Revenue (ttm)
- 143.37B
- Revenue Growth
- -4.45%
- P/S Ratio
- 1.19
- Revenue/Employee
- KRW 319,318,656
- Employees
- 457
- Market Cap
- KRW 173.14B
Revenue Chart
Reyon Pharmaceutical Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 145.93B | -2.37B | -1.60% |
| Dec 31, 2024 | 148.30B | -2.77B | -1.83% |
| Dec 31, 2023 | 151.07B | -2.97B | -1.93% |
| Dec 31, 2022 | 154.04B | 11.24B | 7.87% |
| Dec 31, 2021 | 142.80B | 12.77B | 9.82% |
| Dec 31, 2020 | 130.03B | -1.52B | -1.16% |
| Dec 31, 2019 | 131.56B | 8.57B | 6.97% |
| Dec 31, 2018 | 122.99B | -3.26B | -2.58% |
| Dec 31, 2017 | 126.25B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.